Thymosin Alpha-1 Spray10mg
Thymosin Alpha-1 Spray Canada — Nasal Spray
Thymic Peptide Research Compound — Nasal Spray
Thymosin Alpha-1 is a synthetic peptide analogue of a naturally occurring thymic hormone involved in immune signaling research. It is developed for controlled laboratory investigation within experimental environments.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Thymosin Alpha-1 is a synthetic peptide analogue of a naturally occurring thymic hormone involved in immune signaling research. It is developed for controlled laboratory investigation within experimental environments.
In scientific literature, Thymosin Alpha-1 is studied in models examining immune cell signaling pathways, cytokine modulation frameworks, and receptor-mediated regulatory systems under in vitro and preclinical research conditions.
Third-party tested for purity, ID, quantity.
Thymosin Alpha-1 is a 28–amino acid peptide derived from prothymosin alpha and has been evaluated in research focused on immune-related signaling systems. Experimental studies examine its interaction with immune cell regulatory pathways and cytokine-associated signaling mechanisms within controlled laboratory environments.
Research publications have explored its receptor interaction dynamics and pathway-level regulatory frameworks under structured study conditions.
Thymosin Alpha-1 was identified during early investigations into thymic hormones and immune system regulation. Subsequent biochemical research isolated active peptide fragments responsible for signaling activity within immune-related pathways.
Over time, synthetic analogues were developed to allow controlled experimental study of thymic peptide signaling systems and immune regulatory frameworks.
Laboratory investigations into Thymosin Alpha-1 have focused on immune cell signaling models, cytokine-associated pathway studies, and receptor-mediated regulatory systems. Research frameworks evaluate peptide interaction within immune signaling environments under controlled in vitro and preclinical conditions.
3 of the 4 areas below are addressed directly by a paper cited on this page.
Addressed on this page by Binsfeld 2015, Malinda 1998, Liu 2020. The work appeared in Clin Infect Dis. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
No paper cited on this page reports on cytokine. This heading marks where Thymosin Alpha-1 Spray is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Addressed on this page by Binsfeld 2015. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
Addressed on this page by Binsfeld 2015. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
The references section of this page cites 4 primary papers published between 1998 and 2023 — a limited but non-trivial record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Thymosin Alpha-1 Spray, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Thymosin Alpha-1 Spray is also referred to as Ta1, thymalfasin.
Approved prescription medicines containing the same active ingredient are sold under the brand name Zadaxin. The material supplied here is not those products and is not interchangeable with them. Those are regulated pharmaceuticals manufactured to a licensed specification and dispensed under medical supervision. This is a research compound, and what is published for it is its measured purity and content per lot.
Thymosin Alpha-1 Spray is commonly described online in connection with stronger immune function and resistance to infection. In the research literature the same compound is filed under immune cell signaling pathway models, cytokine regulatory framework studies and thymic peptide interaction research.
The 4 papers cited on this page, published between 1998 and 2023 describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for Thymosin Alpha-1 Spray is per lot, not per product. The current 10mg lot TA1-CA-26I-10 returned 99.562% purity, 11.97 mg measured, 119.7% of the labelled 10 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
The lot code printed on the vial matches the code on the certificate for Thymosin Alpha-1 Spray. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Thymosin Alpha-1 Spray in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
Thymosin Alpha-1 Spray ships as a prepared solution rather than as lyophilized powder, so it is already past the point at which a powder would be reconstituted. That shortens handling but tightens storage: a compound in solution is less stable than the same compound dry, and refrigeration from arrival onward is the relevant control.
The stability window for a solution is shorter than the shelf life of a sealed lyophilized vial of the same compound. Records for laboratory work in this format should note the date the unit was opened, not only the date it was received.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized Thymosin Alpha-1. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Thymosin alpha-1 stimulates endothelial cell migration, angiogenesis, and wound healing.
PubMedImpact of the immunomodulating peptide thymosin alpha-1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
PubMedThymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells. Clin Infect Dis 71(16):2150–2157.
PubMedA Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection. J Infect Dis 227(11):1255–1265.
PubMedRelated
Eppix Flash Sale −30%Peptides
Triple GIP / GLP-1 / Glucagon Agonist · 10, 20, 40 & 120 mg Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.
RETA-CA-26F-1099.637%
11.76 mg / 10 mg
$41.96$59.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Dual GIP / GLP-1 Agonist · 10, 30 & 65 mg Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.
TIRZ-CA-26G-1099.634%
11.42 mg / 10 mg
$24.46$34.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
GLP-1 Receptor Agonist · 10 mg Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.
10 mgSEMA-CA-26F-1099.504%
11.27 mg / 10 mg
$38.46$54.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Selective Amylin Agonist (LY3841136) · 10 mg This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
10 mgELOR-CA-26G-1099.810%
12.42 mg / 10 mg
$101.46$144.95CAD
Flash sale ends in
